Nanoparticle Platforms for Antigen-Specific Immune Tolerance

Front Immunol. 2020 May 20:11:945. doi: 10.3389/fimmu.2020.00945. eCollection 2020.

Abstract

Innovative approaches in nanoparticle design have facilitated the creation of new formulations of nanoparticles that are capable of selectively calibrating the immune response. These nanomaterials may be engineered to interact with specific cellular and molecular targets. Recent advancements in nanoparticle synthesis have enabled surface functionalization of particles that mimic the diversity of ligands on the cell surface. Platforms synthesized using these design principles, called "biomimetic" nanoparticles, have achieved increasingly sophisticated targeting specificity and cellular trafficking capabilities. This holds great promise for next generation therapies that seek to achieve immune tolerance. In this review, we discuss the importance of physical design parameters including size, shape, and biomimetic surface functionalization, on the biodistribution, safety and efficacy of biologic nanoparticles. We will also explore potential applications for immune tolerance for organ or stem cell transplantation.

Keywords: immunity; nanoparticles; rejection; tolerance; transplant.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Antigens / immunology*
  • Antigens / metabolism
  • Biomimetic Materials*
  • Drug Compounding
  • Graft Rejection / immunology
  • Graft Rejection / metabolism
  • Graft Rejection / prevention & control*
  • Graft Survival / drug effects*
  • Humans
  • Immunosuppressive Agents / chemistry
  • Immunosuppressive Agents / pharmacology*
  • Nanomedicine
  • Nanoparticles*
  • Organ Transplantation / adverse effects*
  • Surface Properties
  • Transplantation Tolerance / drug effects*

Substances

  • Antigens
  • Immunosuppressive Agents